by Mark Mascolini, National AIDS Treatment Advocacy Project 7th International AIDS Society Conference, Kuala Lumpur, June 2013: Healthcare provider-initiated HIV tests accounted for a big proportion of acute HIV diagnoses among men who have sex with men (MSM) in France, more than doubling chances of HIV…Read More

7th International AIDS Society Conference, Kuala Lumpur, June 2013: A French study shows that people who start HIV treatment with CD4 counts above 500 had much lower HIV reservoir levels and higher CD4 counts over time than those who started below 500. Researchers followed 309 people…Read More

7th International AIDS Society Conference, Kuala Lumpur, June 2013: The new integrase inhibitor dolutegravir showed better suppression of HIV at 48 weeks than raltegravir (Isentress). Other benefits from taking the once-a-day pill included fewer people who had uncontrolled HIV and who had developed drug resistance. The…Read More

7th International AIDS Society Conference, Kuala Lumpur, June 2013: A non-randomized Swiss study of 290 people showed that using a novel scoring system of six surrogate markers could help establish best practices for starting HIV meds in early infection — an area of HIV care that…Read More

7th International AIDS Society Conference, Kuala Lumpur, June 2013: Researchers from a Spanish study reported on a non-invasive way to measure liver stiffness that may help predict the risk of liver disease progression in people who are co-infected with HIV and hepatitis C. This method, called…Read More